Bristol-Myers Squibb Co BMY 价格预测与展望

Q: 技术分析指标如何适用于 BMY？

根据技术分析，Bristol-Myers Squibb Co 的综合信号为 Buy。Bristol-Myers Squibb Co 有 4 个买入信号，1 个中性信号和 2 个卖出信号。

Q: BMY 的斐波那契回调水平是多少？

Bristol-Myers Squibb Co 的斐波那契回调水平是 在 50% 和 61.8% 之间。

Q: Bristol-Myers Squibb Co 的 RSI 是多少？

Bristol-Myers Squibb Co 的 RSI 目前为 49.55，表明处于 中立 状态

Q: Bristol-Myers Squibb Co 接下来 12 个月的价格是多少？

Bristol-Myers Squibb Co BMY 接下来 12 个月的价格预计为 $56.91。

Q: Bristol-Myers Squibb Co 预计会涨到多高？

据华尔街分析师称，Bristol-Myers Squibb Co 预计将达到 $71.4 的高预测值。

主页

股票

BMY

预测

BMY 股票价格预测

Bristol-Myers Squibb Co

$54.22

-1.88%

$-1.03

收盘价：Jan 20, 16:00:00 GMT-5

$54.29

0.12%

$0.07

盘后：Jan 20, 20:00:00 GMT-5

概述预测收益股息财务数据

360

报告

B-

最终得分

关键数据

前收盘价

$55.26

开盘价

$54.53

当日区间

$53.88 - $54.9

52周范围

$42.52 - $63.33

交易量

10.7M

平均成交量

15.4M

每股收益（TTM）

2.96

股息收益率

4.59%

市值

$110.5B

什么是 BMY？

Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. The company is headquartered in Princeton, New Jersey and currently employs 34,100 full-time employees. The company is engaged in the discovery, development and delivery of transformational medicines for patients facing serious diseases in areas: oncology, hematology, immunology, cardiovascular, neuroscience and other areas. Its growth portfolio includes Opdivo (nivolumab), Opdivo Qvantig (nivolumab and hyaluronidase-nvhy), Yervoy (ipilimumab), Reblozyl (luspatercept-aamt), Opdualag (nivolumab and relatlimab-rmbw), Breyanzi (lisocabtagene maraleucel), Camzyos (mavacamten), Zeposia (ozanimod), Abecma (idecabtagene vicleucel), and Sotyktu (deucravacitinib). Its other growth products include Onureg, Inrebic, and Empliciti. Its legacy portfolio includes Eliquis (apixaban), Revlimid (lenalidomide), Pomalyst/Imnovid (pomalidomide), Sprycel (dasatinib), and Abraxane (paclitaxel albumin-bound particles for injectable suspension). Opdivo (nivolumab) is a fully human monoclonal antibody that binds to the PD-1 on T and NKT cells.

功能特性

交易策略

资源

市场

Utilizing our sophisticated predictive model, we anticipate notable price fluctuations for BMY in the upcoming periods. Looking toward the future, our 2027 projection indicates an average price target of $56.91. The lowest target is $33.43 and the highest is $71.4. Empower your investment choices with our cutting-edge, data-driven analysis!

BMY 股价预测摘要

BMY的顶级分析师评级

基于 33 位分析师对 BMY 的股票评级，更新于 Sep 01, 2025

Neutral

Strong buy

Buy

Hold

Sell

Strong sell

Drawing on detailed analyst evaluations, we have compiled critical insights from expert assessments to provide a balanced outlook for BMY. Analysts observe stable fundamentals but mixed market sentiment, indicating neither significant upside nor downside in the near term. Based on this expert analysis, we hold a balanced perspective on this stock. Our conclusion: BMY is a Neutral candidate.

BMY stock price ended at $55.26 on 星期五, after dropping 2.40%

On the latest trading day Jan 16, 2026, the stock price of BMY fell by 2.40%, dropping from $56.46 to $55.26. During the session, the stock saw a volatility of 2.65%, with prices oscillating between a daily low of $55.10 and a high of $56.56. On the latest trading day, the trading volume for BMY rose by 1.8M shares, despite the declining prices. This uptick in volume may signal heightened risk in the near term. In total, 13.7M shares were traded, with a market value of approximately $112.4B.

BMY 技术面信号

技术面信号摘要

购买信号 4

中性信号 1

卖出信号 2

Strong Sell

Sell

Neutral

Buy

Strong Buy

BMY目前显示4个买入信号和2个卖出信号。该股票自12:00 AM以来一直处于下降趋势状态，在此期间价格总变动为-3.09%。总体而言，技术指标显示中期前景为Buy。

BMY 的看涨/看跌信号

我们的算法通过分析移动平均线、RSI、MACD 和成交量等关键指标，为 BMY 生成看涨和看跌信号。这些见解可助您做出明智的投资决策。

后续问题

技术分析指标如何适用于 BMY？



BMY 的斐波那契回调水平是多少？



Bristol-Myers Squibb Co 的 RSI 是多少？



Bristol-Myers Squibb Co 接下来 12 个月的价格是多少？



Bristol-Myers Squibb Co 预计会涨到多高？



Bristol-Myers Squibb Co（BMY）价格

BMY 股价走势图